RECORD #88737
349403045 | CH | 15063553 | | 1281713 | 5/15/2003 12:00:00 AM | Renal failure | | DIS | Admission Date: 0/29/2003 Report Status:
Discharge Date: 4/28/2003
****** DISCHARGE ORDERS ******
WOODMORE , RYAN 721-51-59-9
Fordauuxvan
Service: RNM
DISCHARGE PATIENT ON: 1/19/03 AT 04:00 PM
CONTINGENT UPON Not Applicable
WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES
Attending: MCCARTHY , ELVIS RAYMOND , M.D. , PH.D.
CODE STATUS:
Full code
DISPOSITION: Home
DISCHARGE MEDICATIONS:
PHOSLO ( CALCIUM ACETATE ) 1 , 334 MG PO TID
Instructions: with meals
CATAPRES ( CLONIDINE HCL ) 0.3 MG/DAY TP Q168H
HOLD IF: sbp&lt;100
ERYTHROPOIETIN ( EPOETIN ALFA ) 4 , 000 UNITS SC 3x/week
LABETALOL HCL 600 MG PO QID HOLD IF: sbp&lt;100 , hr&lt;50
Food/Drug Interaction Instruction
Take consistently with meals or on empty stomach.
LISINOPRIL 40 MG PO QD HOLD IF: sbp&lt;100
Override Notice: Override added on 0/15/03 by
HOLLIBAUGH , HUMBERTO , M.D.
on order for POTASSIUM CHLORIDE IV ( ref # 43969635 )
POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM
CHLORIDE Reason for override: will monitor
Previous override information:
Override added on 0/15/03 by SILVEY , HECTOR , M.D.
on order for POTASSIUM CHLORIDE IMMED. REL. PO ( ref #
49205452 )
POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM
CHLORIDE Reason for override: will monitor
PREDNISONE 10 MG PO QOD
ZOCOR ( SIMVASTATIN ) 10 MG PO QHS
Food/Drug Interaction Instruction
Avoid grapefruit unless MD instructs otherwise.
Override Notice: Override added on 9/11/03 by
UTLEY , ANDRE , M.D.
on order for NEPHROCAPS PO ( ref # 42108796 )
POTENTIALLY SERIOUS INTERACTION: SIMVASTATIN &amp; NIACIN ,
VIT. B-3 Reason for override: will monitor
FK506 ( TACROLIMUS ) 1 MG PO Q12H X 60 Days
Food/Drug Interaction Instruction
Separate antacids by at least two hours and avoid
grapefruit juice
NEPHROCAPS ( NEPHRO-VIT RX ) 1 TAB PO QD
Alert overridden: Override added on 9/11/03 by
BIRCH , BOYD , M.D.
POTENTIALLY SERIOUS INTERACTION: SIMVASTATIN &amp; NIACIN ,
VIT. B-3 Reason for override: will monitor
NIFEDIPINE ( SUSTAINED RELEASE ) ( NIFEDIPINE ( S... )
30 MG PO QD Food/Drug Interaction Instruction
Avoid grapefruit unless MD instructs otherwise.
DOXERCALCIFEROL 2.5 MCG PO QD
RENAGEL 800 MG PO TID
Instructions: please give only with meals. thanks.
KEFLEX ( CEPHALEXIN ) 500 MG PO QD X 7 Days
FLEXERIL ( CYCLOBENZAPRINE HCL ) 10 MG PO TID
PRN back pain
COLCHICINE 0.6 MG PO QOD
DIET: House / ADA 1800 cals/day / Renal diet (FDI)
ACTIVITY: Resume regular exercise
FOLLOW UP APPOINTMENT( S ):
Kidney Doctor - Dr. Rattanasinh , February at 8:40 am 7/11/03 scheduled ,
Dialysis at Seh Quillei Rehabilitation Hospital Thurs 11/22 at 11:30 am ,
No Known Allergies
ADMIT DIAGNOSIS:
end stage renal disease
PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission )
Renal failure
OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay
dm ( diabetes mellitus ) htn ( hypertension ) sleep apnea ( sleep
apnea ) gout ( gout ) depression
( depression ) obesity ( obesity ) left total hip replacement
OPERATIONS AND PROCEDURES:
None
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. )
None
BRIEF RESUME OF HOSPITAL COURSE:
PATIENT IDENTIFICATION: 50 yo male s/p renal transplant presents will
acute on chronic renal failure.
HISTORY OF PRESENT ILLNESS: 50 yo male with ESRD secondary to HTN , on
hemodialysis from 94-99 , s/p cadaveric renal transplant in 1/8 Over
the past few yrs , pt with increasing Cr: 4 in 2001 , 7 in 2002 , 8 in
early February of this year. He was in his USOH until 1 wk ago when he
developed R axilla infection ( hidradenitis suppurativa ) + DOE. Seen in
urgent care 2/3 , given keflex. Seen in renal clinic 5/14 and labs
revealed: Cr of 10 , bicarb 6 , k 6.8. Pt then sent to ED.
HOSPITAL COURSE:
RENAL: Pt admitted with acute on chronic failure. The etiology was
unclear. His FK level was 4.8 , his UA was normal , urine eos were
negative. His low bicarb was due to his underlying renal failure , and
his non-complaince with taking his bicarb replacement at home.
He was started on D5W + 3 amps HCO3 and was ultimately taken to
dialysis 1/6 due to his bicarb. As per renal his immunosupressive
regimen was changed. His cellcept was discontinued , his prednisone was
decreased to 10 qod , and his FK dose was decreased from 2 to 1mg bid ,
and was then to end after a period of 60 days. The patients K was
initially at 6.8. It subsequently decreased with kayexalate and
dialysis. The patient iPTH was checked and elevated at 399. He was to
continue dialysis upopn discharge.
ID - The patient was on renally dosed ancef for a right axilla
skin infection which improved during his hospitalization. His blood
cultures were negative to date at the time of discharge. His is to
finish a 7 day course of keflex as an outpatient. The patient
complained of right ankle pain on 6/9 , a plain film revealed no
fracture.
PULM: The patient had an incidental finding of a pulmonary nodule on
his CXR. A CT revealed that this was just his first right
costo-chondrojunction with osteophytes.
ADDITIONAL COMMENTS: Return to the emergency room or call your doctor for any concern.
Follow up with your kidney doctor Dr. Doorley
Follow up with your primary care doctor for the infection in your arm.
DISCHARGE CONDITION: Stable
TO DO/PLAN:
No dictated summary
ENTERED BY: KUBA , CAREY , M.D. ( SL80 ) 1/19/03 @ 12
****** END OF DISCHARGE ORDERS ******
[report_end]
